Abstract:Objective: To study the clinical outcomes of assistant treatment proposals for infertile women with polycystic ovary syndrome (PCOS). Methods: PCOS patients were divided into four groups according to the assistant treatment proposals between Jan 2003 and Dec 2007 in Reproductive Medicine Center of the Provincial Hospital Affiliated to Shandong University. The four proposals were letrozole (LE) or clomiphene (CC) citrate ovulation induction group, in vitro fertilization and embryo transplantation group, ultrasound-guided immature follicle puncture group, and in vitro maturation and fertilization of oocytes from unstimulated cycles group. The treatment results were analyzed. Results: (1) The ovulation rate was 66% (38/58) vs 47% (21/45). The mean endometrial thickness [(0.89 +/- 0.13) vs (0.78 +/- 0.08) cm] and cervical mucus score (11.9 +/- 1.8 vs 9.9 +/- 1.8) on the day of human chorionic gonadotropin (hCG) administration in LE group were both higher than that in CC group, while mature follicle (1.08 +/- 0.28 vs 1.73 +/- 0.59) and serum estradiol level [(983 +/- 138) vs (1676 +/- 372) pmol/L] in LE group were lower than that in CC group (P < 0.05). (2) One southend five hundred and eighty-four patients accepted in vitro fertilization-embryo transplantation therapy because of PCOS (PCOS group) and 1615 patients because of tube factors (control group). The patients' ages and infertility years were matched between the two groups. Total doses of Gn [(980 +/- 1192) vs (1194 +/- 1389) IU] of PCOS group were lower than those of control group. The mean days of using gonadotropin [(9.6 +/- 1.8) vs (9.5 +/- 1.8) d], serum estradiol (E(2)) levels on the hCG day [(15 752 +/- 6206) vs (9675 +/- 4818) pmol/L], mean obtained oocytes (21 +/- 6 vs 9 +/- 3), mean fertilized oocytes (15 +/- 6 vs 7 +/- 3) and mean cleavaged oocytes (12.9 +/- 5.7 vs 5.7 +/- 2.8) of PCOS group were higher than those of the control group (P < 0.05). Moderate and severe ovarian hyperstimulation syndrome (OHSS) rates (4.86% vs 1.67%) of PCOS group were higher than that of the control group. The pregnant rate (44.7% vs 45.0%)of PCOS group was similar to the control group (P > 0.05). (3) One hundred and nine PCOS patients were given ultrasound-guided immature follicle puncture therapy. After treatment, the testosterone level, luteinizing hormone (LH) level and LH/follicle stimulating hormone (FSH) ratio of the patients became normal. The basic follicle number decreased. (4) A total of 304 in vitro maturation cycles were performed. After embryo transfer, 76 pregnancies were reported. Conclusions: There are many choices for the infertile patients with PCOS, such as LE or CC citrate ovulation induction, in vitro fertilization and embryo transplantation, ultrasound-guided immature follicle puncture, and in vitro maturation and fertilization of oocytes from unstimulated cycles. We can provide individualized treatment according to the medical treatment conditions, doctors' professional capability and the patients' situation.

[Fertilization in Vitro and Embryo Transfer by Combined Long-Acting Gonadotropin Releasing Hormone Agonist and Gonadotropin for Superovulation in Patients with Refractory Polycystic Ovary Syndrome].

Letrozole Stimulation in Endometrial Preparation for Cryopreserved–thawed Embryo Transfer in Women with Polycystic Ovarian Syndrome: A Pilot Study

Influence of long-acting GnRH agonist on outcome of frozen thawed embryo transfer cycle in patients with polycystic ovarian syndrome

Application of Letrozole Inhibitors in Polycystic Ovary Syndrome Receiving Gonadotropin-Releasing Hormone Antagonist Protocols

GnRHa combined with low dose hCG trigger in in vitro fertilization treatment of polycystic ovary syndrome high responders

Successive and Cyclic Oral Contraceptive Pill Pretreatment Improves IVF/ICSI Outcomes of PCOS Patients and Ameliorates Hyperandrogenism and Antral Follicle Excess.

[Outcome of in Vitro Fertilization-Embryo Transfer in Treatment of Polycystic Ovarian Syndrome].

A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome.

Study of Combined Use of Clomiphene Citrate and Gonadotropins on the Infertile Patients with PCOS

Letrozole combined with low dose highly purified human menopausal gonadotropin for ovulation induction in clomiphene citrate-resistant infertile women with polycystic ovary syndrome:a prospective study

In Vitro Maturation and Fertilization of Oocytes from Unstimulated Cycles in Women with Infertility Due to Polycystic Ovary Syndrome

Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?

Effect of dual trigger by using GnRH agonist combined with low-dose HCG on clinical outcomes in PCOS patients undergoing IVF-ET

Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs.

Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility

[Treatment of Polycystic Ovarian Syndrome with Anovulatory Infertility by Ultrasound-Guided Immature Follicle Aspiration].

GnRH agonist pretreatment for frozen embryo transfer among women with polycystic ovary syndrome: a narrow systematic review and meta-analysis of randomized controlled trials

Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial

Comparison of two in vitro gonadotrophin priming protocols in maturation treatment of patients with polycystic ovary syndrome

A Modified Ultra-Long Down-Regulation Protocol for Infertile Patients with PCOS in IVF/ICSI-ET and Its Curative Effect

[Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome]